Phenylpropanoids are secondary metabolites widely distributed in plants. They are believed to protect human cells against oxidative stress and in turn, to prevent various diseases associated with it, such as cancer, cardiovascular, and neurodegenerative disorders as well [2,3]. Recently, many natural phenylpropanoids have emerged as a particularly promising class of small molecules able to inhibit β-amyloid aggregation and disrupt preformed amyloid fibrils that represent important targets in the development of pharmacological treatments of Alzheimer’s disease (AD) [4]. Unfortunately, natural phenylpropanoids often have poor pharmacokinetic properties and low bioavailability. In this frame an interesting approach in the design of new bioacti...
A diphenylpropynone derivative, DPP2, has been recently demonstrated to target metal-associated amyl...
The rationale to define the biological and molecular parameters derived from structure–activity rela...
Alzheimer’s disease (AD), the most common form of dementia, is characterized by extracellular plaque...
Phenylpropanoids are secondary metabolites widely distributed in plants. They are believed to protec...
Alzheimer's disease (AD) is a multifactorial pathology that requires multifaceted agents able to add...
Alzheimer's disease (AD) is a multifactorial pathology that requires multifaceted agents able to add...
A new and concise fragment-based approach towards artificial (but "natural-based") complex polypheno...
In this study natural-based complex polyphenols, obtained through a smart synthetic approach, have b...
: Alzheimer's disease (AD) is a chronic, complex neurodegenerative disorder mainly characterized by ...
A few symptomatic drugs are currently available for Alzheimer’s Disease (AD) therapy, but thes...
Alzheimer’s disease (AD) is a progressive neurodegenerative brain disorder characterized by memory l...
Alzheimer's disease (AD) is a multifactorial disease that is characterized by the formation of ...
Alzheimer’s disease (AD) is a multifactorial syndrome, with a complex interplay of genetic and bioch...
Parkinson's and Alzheimer's disease are the two most common neurological disorders in humans. Both c...
Both amyloid-?? (A??) and transition metal ions are shown to be involved in the pathogenesis of Alzh...
A diphenylpropynone derivative, DPP2, has been recently demonstrated to target metal-associated amyl...
The rationale to define the biological and molecular parameters derived from structure–activity rela...
Alzheimer’s disease (AD), the most common form of dementia, is characterized by extracellular plaque...
Phenylpropanoids are secondary metabolites widely distributed in plants. They are believed to protec...
Alzheimer's disease (AD) is a multifactorial pathology that requires multifaceted agents able to add...
Alzheimer's disease (AD) is a multifactorial pathology that requires multifaceted agents able to add...
A new and concise fragment-based approach towards artificial (but "natural-based") complex polypheno...
In this study natural-based complex polyphenols, obtained through a smart synthetic approach, have b...
: Alzheimer's disease (AD) is a chronic, complex neurodegenerative disorder mainly characterized by ...
A few symptomatic drugs are currently available for Alzheimer’s Disease (AD) therapy, but thes...
Alzheimer’s disease (AD) is a progressive neurodegenerative brain disorder characterized by memory l...
Alzheimer's disease (AD) is a multifactorial disease that is characterized by the formation of ...
Alzheimer’s disease (AD) is a multifactorial syndrome, with a complex interplay of genetic and bioch...
Parkinson's and Alzheimer's disease are the two most common neurological disorders in humans. Both c...
Both amyloid-?? (A??) and transition metal ions are shown to be involved in the pathogenesis of Alzh...
A diphenylpropynone derivative, DPP2, has been recently demonstrated to target metal-associated amyl...
The rationale to define the biological and molecular parameters derived from structure–activity rela...
Alzheimer’s disease (AD), the most common form of dementia, is characterized by extracellular plaque...